RxDoctor Payments Data

Katie Wendt, PA

Physician Assistant · Jacksonville, FLNPI 1306292644

Payments from drug & device makers

$4,130in general payments, 2019–2025

Across 212 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$495
  • Lilly USA, LLC$399
  • Abbott$322
  • Dexcom, Inc.$288
  • AstraZeneca$287
  • Amgen$244
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,03098%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,130 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$11,428
Medicare patients
100
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide51$70,829
OzempicSemaglutide28$47,002
JardianceEmpagliflozin17$22,026
EliquisApixaban19$19,898
TrulicityDulaglutide11$8,325
Spiriva RespimatTiotropium Bromide12$6,160
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$4,033
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$2,367
Atorvastatin Calcium182$1,594
SynthroidLevothyroxine Sodium12$1,575
Albuterol Sulfate HfaAlbuterol Sulfate75$1,493
Gabapentin84$1,239
Rosuvastatin Calcium90$1,120
Lacosamide22$1,114
Omeprazole70$1,081

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$399$79,15462 claims
Novo NordiskOzempic$495$47,00228 claims
Boehringer IngelheimJardiance, Spiriva Respimat$176$28,18729 claims
PfizerEliquis$178$19,89819 claims
AbbVieSynthroid$200$1,57512 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$27$71984 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →